Amicus Therapeutics’ first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy.

The graduate engineer has Fabry disease, which damages the heart, kidneys and nervous system, and cannot access treatment in his home country. The Home Office says it still intends to remove him ...